This course has expired. View available courses.
Cardiovascular, Diabetes
Translating the New Evidence in the Management of Type 2 Diabetes – Ordre des pharmaciens du Québec (OPQ)
DURATION
PROFESSION
# OF CREDITS
1.5
ACCREDITATION
EXPIRY DATE
2019-03-27
Learning objectives
Upon successful completion of this continuing education lesson, participants will be able to:
- Review the impact of underlying cardiovascular disease on antihyperglycemic selection
- Examine new evidence that may impact antihyperglycemic selection since the November 2016 Diabetes Canada Update
- Discuss the significance of CVD primary prevention results with antihyperglycemics
- Review the selection of antihyperglycemic medication for a person without CVD who is not reaching glycemic targets with metformin monotherapy
Cost of course:
Free